Angioedema hereditario tipo 1, limitaciones de la terapia profiláctica con lanadelumab: a propósito de un caso
This case of hereditary angioedema type 1 presents the difficulty in the treatment and the relapse of the patient after trying various therapies, as well as the finding of the adverse effect presented to the prophylactic medication with Lanadelumab, which has been poorly documented in the literature medical worldwide.
Authors
- Martha Lizeth Fonseca-Becerra (ORCID: https://orcid.org/0009-0004-0198-0909)
- Juan Sebastián Betancur-Castro (ORCID: https://orcid.org/0009-0002-3484-3674)
- Leidy Camila Perilla-García (ORCID: https://orcid.org/0009-0003-1709-3848)
Institutions
- Universidad Autónoma de Bucaramanga (CO)
- Military University Nueva Granada (CO)
- Fundación Universitaria Juan N. Corpas (CO)
Publication Details
- Journal
- Revista Alergia México
- Published
- 2024-12-27
- DOI
- https://doi.org/10.29262/ram.v71i4.1323
- Primary Topic
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Type
- article
- Field-Weighted Citation Impact
- 0.00